Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany.
Department of Virology (2/01), Paul Ehrlich Institute, Langen, Germany.
Liver Int. 2024 Oct;44(10):2773-2792. doi: 10.1111/liv.16048. Epub 2024 Jul 30.
The hepatitis B e antigen (HBeAg)-negative infection Phase 3 is characterized by no or minimal signs of hepatic inflammation and the absence of hepatic fibrosis. However, underlying molecular mechanisms leading to this benign phenotype are poorly understood.
Genotype A, B and D HBeAg-negative patient isolates with precore mutation G1896A from Phase 3 were analysed in comparison with respective HBeAg-positive rescue mutant and HBeAg-positive wild-type reference genomes regarding differences in viral replication, morphogenesis, infectivity and impact on NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE)-dependent gene expression and cellular kinome.
In comparison with reference genomes, the patient isolates are characterized by a lower intra- and extracellular hepatitis B surface antigen (HBsAg)-amount, and HBsAg-retention in the endoplasmic reticulum. Rescue of HBeAg expression increased HBsAg-amount but not its release. Expression of the isolated genomes is associated with a higher Nrf2/ARE-dependent gene expression as compared to reference genomes independent of HBeAg expression. Kinome analyses revealed a decreased activity of receptors involved in regulation of proliferative pathways for all patient isolates compared to the reference genomes. No specific conserved mutations could be found between all genomes from Phase 3.
HBeAg-negative genomes from Phase 3 exhibit distinct molecular characteristics leading to lower HBsAg synthesis and release, enhanced oxidative stress protection and decreased activity of key kinases, triggering an antiproliferative stage, which might contribute to the lower probability of hepatocellular carcinoma. The observed differences cannot be associated with loss of HBeAg or specific mutations common to all analysed isolates, indicating the phenotype of Phase 3 derived genomes to be the result of a multifactorial process likely reflecting a conserved natural selection process.
乙肝 e 抗原(HBeAg)阴性感染的第 3 期的特征是没有或几乎没有肝脏炎症的迹象,也没有肝纤维化。然而,导致这种良性表型的潜在分子机制还知之甚少。
分析了基因型 A、B 和 D 的 HBeAg 阴性患者第 3 期的前核心突变 G1896A 分离株,与各自的 HBeAg 阳性挽救突变和 HBeAg 阳性野生型参考基因组进行比较,比较了病毒复制、形态发生、感染性以及对 NF-E2 相关因子 2(Nrf2)/抗氧化反应元件(ARE)依赖性基因表达和细胞激酶组的影响。
与参考基因组相比,患者分离株的细胞内和细胞外乙型肝炎表面抗原(HBsAg)量较低,并且 HBsAg 滞留在内质网中。HBeAg 表达的挽救增加了 HBsAg 的量,但没有增加其释放。与参考基因组相比,分离基因组的表达与更高的 Nrf2/ARE 依赖性基因表达相关,而与 HBeAg 表达无关。与参考基因组相比,所有第 3 期分离株的激酶组分析显示,参与调节增殖途径的受体活性降低。在所有第 3 期的基因组之间没有发现特定的保守突变。
第 3 期的 HBeAg 阴性基因组表现出明显的分子特征,导致 HBsAg 合成和释放减少,氧化应激保护增强,关键激酶活性降低,引发抗增殖阶段,这可能有助于降低肝细胞癌的概率。所观察到的差异不能与 HBeAg 缺失或所有分析分离株共有的特定突变相关联,表明第 3 期衍生基因组的表型是多因素过程的结果,可能反映了保守的自然选择过程。